Fidia In
Eye care
WE ARE FIDIA
We are an Italian multinational, established in 1946, with a vocation to create solutions to meet new challenges in health and improve people’s true quality of life.
We have understood the regenerating potential of hyaluronic acid since the 1950s and today we are one of the leading global players in the manufacture of hyaluronic acid-based products. Full control of the supply chain, from research to marketing, sets us apart and for this reason we define ourselves as a fully integrated company.
FIDIA IN EYE CARE
We are dedicated to advancing eye care worldwide, supporting ophthalmologists and optometrists with innovative therapies, technologies, and professional engagement.
Through our commitment to ophthalmic diseases, we provide solutions that help healthcare professionals improve patient outcomes while staying connected with the latest developments in eye care.
OUR INNOVATION
Combining science, technology, and expertise to drive progress in ophthalmology.
FHA 1.0®
the patented Fidia Hyaluronic Acid 1.0
At Fidia, innovation drives our commitment to eye care.
Our proprietary FHA1.0® formulation harnesses the benefits of hyaluronic acid to support ocular surface health and patient comfort. Designed for ophthalmic applications, FHA1.0® combines advanced formulation technology with proven biocompatibility, offering eye care professionals a reliable solution for managing dry eye and other ocular surface conditions.
OUR APPROACH
We advance eye care for healthcare professionals through innovative treatments, ophthalmic technologies, and professional collaboration worldwide.
We are committed to eye health through research, innovation, and patient-centered solutions for the full spectrum of visual conditions.
Fidia is deeply committed to advancing eye care through innovation, quality, and patient-centric solutions.
Our dedication to eye care is reflected in our comprehensive range of ophthalmic products designed to treat various conditions such as Dry Eye Disease, Keratoconus, Glaucoma, and Age-Related Macular Degeneration (AMD). We focus on developing treatments that address the underlying causes of these conditions, providing relief from symptoms like dryness, redness, burning, and visual disturbances.
Our commitment to quality ensures that our products are safe, effective, and reliable, meeting the highest standards of regulatory compliance.
From Pathology to Treatment
Exploring eye care challenges and the innovative solutions Fidia provides for healthcare professionals.
DISCOVER OUR SOLUTIONS
We offer a comprehensive range of ophthalmic therapies and technologies designed to support eye care professionals in managing ocular conditions effectively. From dry eye and keratoconus to corneal health and ocular safety, our solutions combine innovation, clinical expertise, and patient-focused outcomes to help clinicians deliver optimal care.